Differential knockdown of TGF-β ligands in a three-dimensional co-culture tumor- stromal interaction model of lung cancer.

Abstract:

BACKGROUND:Transforming growth factor (TGF)-β plays a pivotal role in cancer progression through regulating cancer cell proliferation, invasion, and remodeling of the tumor microenvironment. Cancer-associated fibroblasts (CAFs) are the predominant type of stromal cell, in which TGF-β signaling is activated. Among the strategies for TGF-β signaling inhibition, RNA interference (RNAi) targeting of TGF-β ligands is emerging as a promising tool. Although preclinical studies support the efficacy of this therapeutic strategy, its effect on the tumor microenvironment in vivo remains unknown. In addition, differential effects due to knockdown of various TGF-β ligand isoforms have not been examined. Therefore, an experimental model that recapitulates tumor-stromal interaction is required for validation of therapeutic agents. METHODS:We have previously established a three-dimensional co-culture model of lung cancer, and demonstrated the functional role of co-cultured fibroblasts in enhancing cancer cell invasion and differentiation. Here, we employed this model to examine how knockdown of TGF-β ligands affects the behavior of different cell types. We developed lentivirus vectors carrying artificial microRNAs against human TGF-β1 and TGF-β2, and tested their effects in lung cancer cells and fibroblasts. RESULTS:Lentiviral vectors potently and selectively suppressed the expression of TGF-β ligands, and showed anti-proliferative effects on these cells. Furthermore, knockdown of TGF-β ligands attenuated fibroblast-mediated collagen gel contraction, and diminished lung cancer cell invasion in three-dimensional co-culture. We also observed differential effects by targeting different TGF-β isoforms in lung cancer cells and fibroblasts. CONCLUSIONS:Our findings support the notion that RNAi-mediated targeting of TGF-β ligands may be beneficial for lung cancer treatment via its action on both cancer and stromal cells. This study further demonstrates the usefulness of this three-dimensional co-culture model to examine the effect of therapeutic agents on tumor-stromal interaction.

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Horie M,Saito A,Noguchi S,Yamaguchi Y,Ohshima M,Morishita Y,Suzuki HI,Kohyama T,Nagase T

doi

10.1186/1471-2407-14-580

subject

Has Abstract

pub_date

2014-08-09 00:00:00

pages

580

issn

1471-2407

pii

1471-2407-14-580

journal_volume

14

pub_type

杂志文章
  • The release of tryptase from mast cells promote tumor cell metastasis via exosomes.

    abstract:BACKGROUND:Cancer cells release exosomes and can be taken up by mast cells (MCs), but the potential functional effects of MCs on tumor metastasis remain unknown. METHOD:Exosomes were isolated from the lung adenocarcinoma cell line A549, and the uptake of PKH26-labeled exosomes by bone marrow MCs was examined via flow ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-6203-2

    authors: Xiao H,He M,Xie G,Liu Y,Zhao Y,Ye X,Li X,Zhang M

    更新日期:2019-10-29 00:00:00

  • Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer.

    abstract:BACKGROUND:Ovarian cancer remains the most fatal gynecological malignancy. Current therapeutic options are limited due to late diagnosis in the majority of the cases, metastatic spread to the peritoneal cavity and the onset of chemo-resistance. Thus, novel therapeutic approaches are required. Statins and amino-bisphosp...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07164-x

    authors: Göbel A,Zinna VM,Dell'Endice S,Jaschke N,Kuhlmann JD,Wimberger P,Rachner TD

    更新日期:2020-07-29 00:00:00

  • Gefitinib provides similar effectiveness and improved safety than erlotinib for east Asian populations with advanced non-small cell lung cancer: a meta-analysis.

    abstract:BACKGROUND:The first-generation epidermal growth factor receptor tyrosine kinase inhibitors gefitinib and erlotinib have both been proven effective for treating advanced non-small cell lung cancer (NSCLC), especially in East Asian patients. We conducted this meta-analysis to compare their efficacy and safety in treatin...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-018-4685-y

    authors: Zhang W,Wei Y,Yu D,Xu J,Peng J

    更新日期:2018-08-02 00:00:00

  • Prediction of 5-year overall survival in cervical cancer patients treated with radical hysterectomy using computational intelligence methods.

    abstract:BACKGROUND:Computational intelligence methods, including non-linear classification algorithms, can be used in medical research and practice as a decision making tool. This study aimed to evaluate the usefulness of artificial intelligence models for 5-year overall survival prediction in patients with cervical cancer tre...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3806-3

    authors: Obrzut B,Kusy M,Semczuk A,Obrzut M,Kluska J

    更新日期:2017-12-12 00:00:00

  • Randomized controlled trial of an 8-week intervention combining self-care and hypnosis for post-treatment cancer patients: study protocol.

    abstract:BACKGROUND:Cancer has a lot of consequences on patients' quality of life (such as cancer-related fatigue (CRF), sleep difficulties and emotional distress) and on patients' partners and their relationship, such as distress and communication difficulties. These consequences are undertreated, and interventions based on hy...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-5046-6

    authors: Grégoire C,Faymonville ME,Vanhaudenhuyse A,Charland-Verville V,Jerusalem G,Bragard I

    更新日期:2018-11-15 00:00:00

  • Immunoproteomics approach revealed elevated autoantibody levels against ANXA1 in early stage gallbladder carcinoma.

    abstract:BACKGROUND:Early diagnosis is important for the timely treatment of gallbladder carcinoma (GBC) patients and may lead to increased survival outcomes. Here, we have applied serological proteome analysis (SERPA), an immunoproteomics approach, for the detection of 'tumor-associated antigens (TAAs) that elicit humoral resp...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07676-6

    authors: Akhtar J,Priya R,Jain V,Sakhuja P,Agarwal AK,Goyal S,Polisetty RV,Sirdeshmukh R,Kar S,Gautam P

    更新日期:2020-12-01 00:00:00

  • Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes.

    abstract:BACKGROUND:Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer related death in the world with a five-year survival rate of less than 5%. Not all PDAC are the same, because there exist intra-tumoral heterogeneity between PDAC, which poses a great challenge to personalized treatments for PDAC. ...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-018-4546-8

    authors: Zhao L,Zhao H,Yan H

    更新日期:2018-05-29 00:00:00

  • Testosterone inhibits the growth of prostate cancer xenografts in nude mice.

    abstract:BACKGROUND:Traditional beliefs of androgen's stimulating effects on the growth of prostate cancer (PCa) have been challenged in recent years. Our previous in vitro study indicated that physiological normal levels of androgens inhibited the proliferation of PCa cells. In this in vivo study, the ability of testosterone (...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3569-x

    authors: Song W,Soni V,Soni S,Khera M

    更新日期:2017-09-07 00:00:00

  • Preoperative serum 8-hydroxydeoxyguanosine is associated with chemoresistance and is a powerful prognostic factor in endometrioid-type epithelial ovarian cancer.

    abstract:BACKGROUND:Oxidative stress is a widely seen phenomenon in several carcinomas. Increasing evidence also suggests that it has a significant role in the development of epithelial ovarian carcinoma (EOC). 8-Hydroxydeoxyguanosine (8-OHdG) is one of the main indicators of oxidative stress and increased expression of 8-OHdG ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1504-6

    authors: Pylväs-Eerola M,Karihtala P,Puistola U

    更新日期:2015-07-02 00:00:00

  • Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients.

    abstract:BACKGROUND:Circulating tumour DNA (ctDNA) may serve as a measure of tumour burden and a useful tool for non-invasive monitoring of cancer. However, ctDNA is not always detectable in patients at time of diagnosis of metastatic disease. Therefore, there is a need to understand the correlation between ctDNA levels and the...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4637-6

    authors: McEvoy AC,Warburton L,Al-Ogaili Z,Celliers L,Calapre L,Pereira MR,Khattak MA,Meniawy TM,Millward M,Ziman M,Gray ES

    更新日期:2018-07-09 00:00:00

  • The clinical features and treatment modality of esophageal neuroendocrine tumors: a multicenter study in Korea.

    abstract:BACKGROUND:Neuroendocrine tumors (NETs) of the esophagus are extremely rare, and few cases have been reported worldwide. Thus, a comprehensive nationwide study is needed to understand the characteristics of and treatment strategy for esophageal NETs. METHODS:We collected data on esophageal NET patients from 25 hospita...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/1471-2407-14-569

    authors: Lee CG,Lim YJ,Park SJ,Jang BI,Choi SR,Kim JK,Kim YT,Cho JY,Yang CH,Chun HJ,Song SY,Neuroendocrine tumor study group.

    更新日期:2014-08-07 00:00:00

  • Cost-effectiveness analysis of cabazitaxel for metastatic castration resistant prostate cancer after docetaxel and androgen-signaling-targeted inhibitor resistance.

    abstract:BACKGROUND:The aim of our study was to evaluate the cost-effectiveness of cabazitaxel versus abiraterone or enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel who had progression within 12 months while receiving an alternative inhibitor (abiraterone o...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07754-9

    authors: Zhang PF,Xie D,Li Q

    更新日期:2021-01-07 00:00:00

  • Improving gastric cancer preclinical studies using diverse in vitro and in vivo model systems.

    abstract:BACKGROUND:"Biomarker-driven targeted therapy," the practice of tailoring patients' treatment to the expression/activity levels of disease-specific genes/proteins, remains challenging. For example, while the anti-ERBB2 monoclonal antibody, trastuzumab, was first developed using well-characterized, diverse in vitro brea...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2232-2

    authors: Chang HR,Park HS,Ahn YZ,Nam S,Jung HR,Park S,Lee SJ,Balch C,Powis G,Ku JL,Kim YH

    更新日期:2016-03-09 00:00:00

  • Different next-generation sequencing pipelines based detection of tumor DNA in cerebrospinal fluid of lung adenocarcinoma cancer patients with leptomeningeal metastases.

    abstract:BACKGROUND:The nucleic acid mutation status in intracranial metastasis is markedly significant clinically. The goal of the current study was to explore whether the tumor-associated mutations can be detected by different next-generation sequencing (NGS) pipelines in paired cerebrospinal fluid (CSF) and plasma samples fr...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5348-3

    authors: Ge M,Zhan Q,Zhang Z,Ji X,Zhou X,Huang R,Liang X

    更新日期:2019-02-12 00:00:00

  • Cooperation of Sox4 with β-catenin/p300 complex in transcriptional regulation of the Slug gene during divergent sarcomatous differentiation in uterine carcinosarcoma.

    abstract:BACKGROUND:Uterine carcinosarcoma (UCS) represents a true example of cancer associated with epithelial-mesenchymal transition (EMT), which exhibits cancer stem cell (CSC)-like traits. Both Sox and β-catenin signal transductions play key roles in the regulation of EMT/CSC properties, but little is known about their invo...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2090-y

    authors: Inoue H,Takahashi H,Hashimura M,Eshima K,Akiya M,Matsumoto T,Saegusa M

    更新日期:2016-02-03 00:00:00

  • Correction to: Genetic and clinical characterization of BRCA-associated hereditary breast and ovarian cancer in Navarra (Spain).

    abstract::Following publication of the original article [1], the authors reported an error in Figure 2, where the color code of the text boxes is reversed. Figure 2-amended shows the correct color association between the text boxes and the different areas in the map: Navarra, neighbouring communities and other Spanish communiti...

    journal_title:BMC cancer

    pub_type: 杂志文章,已发布勘误

    doi:10.1186/s12885-019-6458-7

    authors: de Sabando AR,Lafuente EU,García-Amigot F,Sánchez AA,Garofalo LM,Moreno S,Ardanaz E,Ramos-Arroyo MA

    更新日期:2019-12-17 00:00:00

  • Favorable prognostic value of SOCS2 and IGF-I in breast cancer.

    abstract:BACKGROUND:Suppressor of cytokine signaling (SOCS) proteins comprise a protein family, which has initially been described as STAT induced inhibitors of the Jak/Stat pathway. Recent in vivo and in vitro studies suggest that SOCS proteins are also implicated in cancer. The STAT5 induced IGF-I acts as an endocrine and par...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/1471-2407-7-136

    authors: Haffner MC,Petridou B,Peyrat JP,Révillion F,Müller-Holzner E,Daxenbichler G,Marth C,Doppler W

    更新日期:2007-07-25 00:00:00

  • The effect of metformin and thiazolidinedione use on lung cancer in diabetics.

    abstract:BACKGROUND:Metformin and the thiazolidinediones (TZDs) may have a protective effect against the development of lung cancer. METHODS:Patients with diabetes mellitus (DM) were identified from the electronic medical records of the Cleveland Clinic. Diabetics with lung cancer were identified then verified by direct review...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-12-410

    authors: Mazzone PJ,Rai H,Beukemann M,Xu M,Jain A,Sasidhar M

    更新日期:2012-09-14 00:00:00

  • Skin cancers in people with albinism in Togo in 2019: results of two rounds of national mobile skin care clinics.

    abstract:BACKGROUND:In people with albinism (PWA), the deficiency of melanin increase the risk of skin cancers. The aim of this study was to determine the prevalence of skin cancers and characteristics of these detected skin cancers (histological types, localization) in PWA in 10 cities in Togo in 2019. METHODS:This is a cross...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07747-8

    authors: Saka B,Akakpo SA,Teclessou JN,Gnossike P,Adam S,Mahamadou G,Kassang P,Elegbede Y,Mouhari-Toure A,Darre T,Kombate K,Pitché P

    更新日期:2021-01-05 00:00:00

  • Impact of chromosomal instability on colorectal cancer progression and outcome.

    abstract:BACKGROUND:It remains presently unclear whether disease progression in colorectal carcinoma (CRC), from early, to invasive and metastatic forms, is associated to a gradual increase in genetic instability and to a scheme of sequentially occurring Copy Number Alterations (CNAs). METHODS:In this work we set to determine ...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-121

    authors: Orsetti B,Selves J,Bascoul-Mollevi C,Lasorsa L,Gordien K,Bibeau F,Massemin B,Paraf F,Soubeyran I,Hostein I,Dapremont V,Guimbaud R,Cazaux C,Longy M,Theillet C

    更新日期:2014-02-22 00:00:00

  • Prognostic significance of stem cell/ epithelial-mesenchymal transition markers in periampullary/pancreatic cancers: FGFR1 is a promising prognostic marker.

    abstract:BACKGROUND:Periampullary cancers (PAC) including pancreatic, ampulla of Vater (AOV), and common bile duct (CBD) cancers are highly aggressive with a lack of useful prognostic markers beyond T stage. However, T staging can be biased due to the anatomic complexity of this region. Recently, several markers related to canc...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-6673-2

    authors: Chong Y,Thakur N,Paik KY,Lee EJ,Kang CS

    更新日期:2020-03-14 00:00:00

  • Population attributable risks of oral cavity cancer to behavioral and medical risk factors in France: results of a large population-based case-control study, the ICARE study.

    abstract:BACKGROUND:Population attributable risks (PARs) are useful tool to estimate the burden of risk factors in cancer incidence. Few studies estimated the PARs of oral cavity cancer to tobacco smoking alone, alcohol drinking alone and their joint consumption but none performed analysis stratified by subsite, gender or age. ...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/s12885-015-1841-5

    authors: Radoï L,Menvielle G,Cyr D,Lapôtre-Ledoux B,Stücker I,Luce D,ICARE Study Group.

    更新日期:2015-10-31 00:00:00

  • A multicentre randomised controlled trial to evaluate the efficacy, morbidity and functional outcome of endoscopic transanal proctectomy versus laparoscopic proctectomy for low-lying rectal cancer (ETAP-GRECCAR 11 TRIAL): rationale and design.

    abstract:BACKGROUND:Total mesorectal excision is the standard surgical treatment for mid- and low-rectal cancer. Laparoscopy represents a clear leap forward in the management of rectal cancer patients, offering significant improvements in post-operative measures such as pain, first bowel movement, and hospital length of stay. H...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/s12885-017-3200-1

    authors: Lelong B,de Chaisemartin C,Meillat H,Cournier S,Boher JM,Genre D,Karoui M,Tuech JJ,Delpero JR,French Research Group of Rectal Cancer Surgery (GRECCAR).

    更新日期:2017-04-11 00:00:00

  • A method to estimate cell cycle time and growth fraction using bromodeoxyuridine-flow cytometry data from a single sample.

    abstract:BACKGROUND:Presently available flow cytometric methods of bromodeoxyuridine (BrdUrd) labelling do not provide information on the cell cycle time (TC) and the growth fraction (GF). In this paper, we describe a novel and simple method to estimate TC and GF from flow cytometric analysis of a single tumour sample after Brd...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-5-122

    authors: Eidukevicius R,Characiejus D,Janavicius R,Kazlauskaite N,Pasukoniene V,Mauricas M,Den Otter W

    更新日期:2005-09-22 00:00:00

  • Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitution.

    abstract:BACKGROUND:High-dose (HD) chemotherapy followed by autologous blood stem-cell transplantation (ASCT) is the standard treatment for multiple myeloma (MM) patients. However, the collection of sufficient peripheral blood stem cell (PBSC) grafts can be challenging, and the question arises whether reinfusion of low-dose gra...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-06873-7

    authors: Sauer S,Pavel P,Schmitt A,Cremer M,Kriegsmann M,Bruckner T,Jordan K,Wuchter P,Müller-Tidow C,Kriegsmann K

    更新日期:2020-04-25 00:00:00

  • The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development.

    abstract:BACKGROUND:In this work, we have conducted a case-control study in order to assess the effect of tobacco and three genetic polymorphisms in XPC, ERCC2 and ERCC5 genes (rs2228001, rs13181 and rs17655) in bladder cancer development in Tunisia. We have also tried to evaluate whether these variants affect the bladder tumor...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-11-101

    authors: Rouissi K,Bahria IB,Bougatef K,Marrakchi R,Stambouli N,Hamdi K,Cherif M,Ben Slama MR,Sfaxi M,Othman FB,Chebil M,Elgaaied AB,Ouerhani S

    更新日期:2011-03-22 00:00:00

  • The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines.

    abstract:BACKGROUND:High-risk neuroblastoma with N-Myc amplification remains a therapeutic challenge in paediatric oncology. Antagonism of pro-death Bcl-2 homology (BH) proteins to pro-survival BH members such as Mcl-1 and Bcl-2 has become a treatment approach, but previous studies suggest that a combined inhibition of Bcl-2 an...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5439-1

    authors: Klenke S,Akdeli N,Stelmach P,Heukamp L,Schulte JH,Bachmann HS

    更新日期:2019-03-18 00:00:00

  • The 2018 Nobel Prize in medicine goes to cancer immunotherapy (editorial for BMC cancer).

    abstract:: ...

    journal_title:BMC cancer

    pub_type: 社论,历史文章

    doi:10.1186/s12885-018-5020-3

    authors: Guo ZS

    更新日期:2018-11-12 00:00:00

  • BioPro-RCMI-1505 trial: multicenter study evaluating the use of a biodegradable balloon for the treatment of intermediate risk prostate cancer by intensity modulated radiotherapy; study protocol.

    abstract:BACKGROUND:Prospective trials have demonstrated the advantage of dose-escalated radiotherapy for the biochemical and clinical control of intermediate risk prostate cancer. Dose escalation improves outcomes but increases risks of urinary and bowel toxicity. Recently the contribution of "spacers" positioned in the septum...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4492-5

    authors: Pasquier D,Bogart E,Bonodeau F,Lacornerie T,Lartigau E,Latorzeff I

    更新日期:2018-05-16 00:00:00

  • Aberrant allele-specific replication, independent of parental origin, in blood cells of cancer patients.

    abstract:BACKGROUND:Allelic counterparts of biallelically expressed genes display an epigenetic symmetry normally manifested by synchronous replication, different from genes subjected to monoallelic expression, which normally are characterized by an asynchronous mode of replication (well exemplified by the SNRPN imprinted locus...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-390

    authors: Dotan ZA,Dotan A,Ramon J,Avivi L

    更新日期:2008-12-25 00:00:00